Evidence map›Paper›PMID 37643136›Full record

ArticleGlobal health action2023

Improving COVID-19 vaccine uptake: a message co-design process for a national mHealth intervention in Colombia.

Nathaly Aya Pastrana, Sandra Agudelo-Londoño, Oscar Franco-Suarez, Jessica Otero Machuca, Deivis Nicolás Guzman-Tordecilla, María Camila López Sánchez, Mariana Rodriguez-Patarroyo, Cristhian Alejandro Rivera-Sánchez, Daniella Castro-Barbudo, Antonio J Trujillo and 2 more

Open access · goldAbstract read
In one paragraph

Article in Global health action, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Nathaly Aya PastranaIMEK Centro de Investigación en Mercadeo & Desarrollo, Santiago de Cali, Colombia.ORCID 0000-0002-0321-2397
Sandra Agudelo-LondoñoInstituto de Salud Pública, Pontificia Universidad Javeriana, Bogotá, Colombia.ORCID 0000-0002-8980-6590
Oscar Franco-SuarezInstituto de Salud Pública, Pontificia Universidad Javeriana, Bogotá, Colombia.ORCID 0000-0001-6960-1777
Jessica Otero MachucaInstituto de Salud Pública, Pontificia Universidad Javeriana, Bogotá, Colombia.ORCID 0000-0002-3466-1881
Deivis Nicolás Guzman-TordecillaDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.ORCID 0000-0002-9419-7056
María Camila López SánchezInstituto de Salud Pública, Pontificia Universidad Javeriana, Bogotá, Colombia.ORCID 0000-0002-9255-5120
Mariana Rodriguez-PatarroyoInstituto de Salud Pública, Pontificia Universidad Javeriana, Bogotá, Colombia.ORCID 0000-0003-4281-9156
Cristhian Alejandro Rivera-SánchezInstituto de Salud Pública, Pontificia Universidad Javeriana, Bogotá, Colombia.ORCID 0000-0001-7173-3074
Daniella Castro-BarbudoInstituto de Salud Pública, Pontificia Universidad Javeriana, Bogotá, Colombia.ORCID 0000-0002-6016-9604
Antonio J TrujilloDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.ORCID 0000-0002-0800-8512
Vidhi ManiarDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.ORCID 0000-0001-9511-1421
Andres I Vecino-OrtizDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.ORCID 0000-0002-8089-2488
Pontificia Universidad Javeriana · COJohns Hopkins University · USUniversity of North Carolina at Chapel Hill · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCOVID-19 vaccination is a global priority. Latin American countries have some of the highest COVID-19 death rates worldwide with vaccination hampered by a variety of reasons, including mis- and disinformation, vaccine hesitancy, and vaccine supply constraints. Addressing vaccine hesitancy through effective messages has been found to help increase vaccine uptake. Participatory processes could be used to co-design health messages for this purpose.

objectiveThis article describes the methodology used to co-design evidence-based audio messages to be deployed in a cohort of individuals through an interactive voice response (IVR) mobile phone survey intervention, aimed towards increasing vaccination uptake in an adult population in Colombia.

methodsParticipants of the COVID-19 vaccination message co-design process included a sample of the general population of the country, representatives of the funder organisation, and research team members. The co-design process consisted of four phases: (1) formative quantitative and qualitative research, (2) message drafting based on the results of the formative research, (3) message content evaluation, and (4) evaluation of the voices to deliver the audio messages; and was informed by reflexive meetings.

resultsThree categories of evidence-based audio messages were co-designed, each corresponding to an arm of the mHealth intervention: (1) factual messages, (2) narrative messages, and (3) mixed messages. An additional fourth arm with no message was proposed for control. The iterative co-design process ended with a total of 14 audio messages recorded to be deployed via the intervention.

conclusionsCo-developing health messages in response to health emergencies is possible. Adopting more context-relevant, participatory, people-centred, and reflexive multidisciplinary approaches could help develop solutions that are more responsive to the needs of populations and public health priorities. Investing resources in message co-design is deemed to have a greater potential for influencing behaviours and improving health outcomes.

Indexed as

COVID-19COVID-19 VaccinesAdultColombiaHealth PrioritiesHumansInterdisciplinary StudiesCOVID-19 Vaccinesbehavior changeCo-designCOVID-19 vaccinationintervention developmentmessage design

Identifiers

PMID37643136
PMCPMC10467523
OpenAlexW4386250185

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.